Lamelle

Lamelle Research Laboratories is a biotechnology research company that manufacture's products locally for the South African market

With a special interest in cosmetic dermatology, all products that are developed follow a rigorous programme of review, research and meticulous production.

Lamelle Research Laboratories was the first to launch Nobel Prize-winning nano-capsulated recombinant human growth factors 100% homologues to human protein in South Africa, which has proven to be popular with doctors and therapists due to its results for anti-ageing under the brand Dermaheal. This is one of many firsts for Lamelle, including Ovelle, the first oral supplement for hormonal pigmentation/melasma.

More innovative firsts from Lamelle:

Launch of Beta Peel - a medical grade salicylic acid peeling system (October 2006)
Launch of the US FDA-cleared Mattioli Transderm (November 2007)
Launch of Portrait plasma resurfacing (February 2007)
Launch of iPulse Intense Pulsed Light technology (September 2006)
Launch of rH growth factors technology (October 2006)
Launch of Ovelle oral antioxidant for hormonal pigment and melasma (May 2007)
Launch of collagen induction therapy (September 2006)
Launch of neurosensory-inhibiting factors in chemical peels (August 2008)
Launch of the new combination Melapeel systems (August 2008)
Launch of pigment-inhibiting peptides used in Luminesce - a first in South Africa (May 2009)
Launch of Clarity and Acnevelle (February 2010)
Launch of Correctives Cathepzyme (October 2011)
Launch of Nourish - the first free radical protection system with propriety ingredients (February 2012)